• Free shipping for orders more than €200
  • Discreet packaging. Secure and confidential
  • 100% moneyback guarantee
  • No prescription required
Klonopin (Clonazepam)

Klonopin (Clonazepam)

€121.00

in stock

Commercial Name: Klonopin, Rivotril
Principal Ingredient: Clonazepam
Utilization: Anti-Anxiety
Available Dosage: 0,5 mg, 1 mg, 2 mg
Category: Anti-Anxiety
Delivery information
Dosage Pills Price To Cart
2.0 mg (EU2EU) 30 pills €121.00
2.0 mg (EU2EU) 60 pills €240.00
2.0 mg (EU2EU) 90 pills €337.00
2.0 mg (EU2EU) 120 pills €410.00
2.0 mg (EU2EU) 180 pills €543.00
Description
Klonopin is useful on my own or as an accessory within the remedy of the Lennox-Gastaut syndrome (petit mal version), akinetic, and myoclonic seizures. In patients with absence seizures (petit mal) who've didn't respond to succinimides, Klonopin may be useful.

aspect effects
The adverse reviews for Klonopin are provided one after the other for sufferers with seizure problems and with panic sickness.

Seizure issues
The most frequently occurring aspect results of Klonopin are referable to CNS melancholy. experience in treatment of seizures has proven that drowsiness has befell in approximately 50% of patients and ataxia in about 30%. In a few cases, these may decrease with time; behavior issues were noted in approximately 25% of patients. Others, listed via device, inclusive of the ones identified in the course of postapproval use of Klonopin are:

Cardiovascular: Palpitations

Dermatologic: Hair loss, hirsutism, skin rash, ankle and facial edema

Gastrointestinal: Anorexia, lined tongue, constipation, diarrhea, dry mouth, encopresis, gastritis, improved urge for food, nausea, sore gums

Genitourinary: Dysuria, enuresis, nocturia, urinary retention

Hematopoietic: Anemia, leukopenia, thrombocytopenia, eosinophilia

Hepatic: Hepatomegaly, temporary elevations of serum transaminases and alkaline phosphatase

Musculoskeletal: Muscle weakness, pains

Miscellaneous: Dehydration, general deterioration, fever, lymphadenopathy, weight loss or advantage

Neurologic: strange eye movements, aphonia, choreiform actions, coma, diplopia dysarthria, dysdiadochokinesis, ‘‘glassy-eyed’’ look, headache, hemiparesis, hypotonia, nystagmus, respiratory depression, slurred speech, tremor, vertigo

Psychiatric: Confusion, despair, amnesia, hysteria, elevated libido, insomnia, psychosis (the behavior effects are much more likely to occur in sufferers with a records of psychiatric disturbances).

the subsequent paradoxical reactions were located: irritability, aggression, agitation, nervousness, hostility, tension, sleep disturbances, nightmares, unusual goals, hallucinations.

respiratory: Chest congestion, rhinorrhea, shortness of breath, hypersecretion in top respiratory passages

Panic disorder
unfavourable occasions all through publicity to Klonopin were obtained through spontaneous document and recorded via clinical investigators the use of terminology in their very own deciding on. consequently, it isn't always viable to provide a meaningful estimate of the proportion of individuals experiencing detrimental activities without first grouping similar types of activities right into a smaller wide variety of standardized occasion categories. within the tables and tabulations that observe, CIGY dictionary terminology has been used to categorise reported damaging events, besides in positive cases wherein redundant phrases were collapsed into extra meaningful phrases, as mentioned under.

The said frequencies of unfavorable events represent the proportion of people who skilled, as a minimum as soon as, a remedy-emergent unfavourable occasion of the type indexed. An occasion become taken into consideration treatment-emergent if it happened for the first time or worsened at the same time as receiving therapy following baseline assessment.

damaging Findings located In brief-time period, Placebo-controlled Trials
damaging occasions associated with Discontinuation Of remedy
typical, the incidence of discontinuation due to damaging occasions turned into 17% in Klonopin as compared to nine% for placebo in the mixed statistics of 6- to 9-week trials.